Weight Loss Research: Mean light timing may influence body mass index, body fat ♦ New obesity treatment prevents bone loss during weight loss ♦ Lean despite many calories

Lean despite many calories Scientists have identified an enzyme in mice that is involved in obesity and metabolic disruptions associated with it, such as type 2 diabetes. When the investigators turned off the enzyme in experiments, the animals did not gain any weight despite being fed a diet that was rich in fat and caloric content. Furthermore, they did not develop diabetes.

Researchers boost body's inflammation-reduction mechanism to combat obesity-fueled disease Augmenting a naturally occurring molecule in the body can help protect against obesity-related diseases by reducing inflammation in the fat tissues.

Mean light timing may influence body mass index, body fat The timing of exposure to moderate levels of light may influence body mass index and body fat, a new study suggests. Results show that people with more exposure to moderate or higher intensity light earlier in the day had lower body mass index and percent body fat

Gut hormone-based medications alter how the brain responds to food Gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, have also been shown to reduce body weight. Researchers have been working to understand how. A new study sheds light on how GLP-1 receptor agonists alter the brain's response to food, possibly reducing cravings and increasing satisfaction.

New obesity treatment prevents bone loss during weight loss Using the intestinal hormone GLP-1 in obesity treatment prevents the loss of bone mass otherwise frequently associated with major weight loss The results may have a significant bearing on future obesity treatment.